Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in NBIX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 13.7M | $2.31B | +2.4% | 13.637% | 0.03% |
| 2 | JPMORGAN CHASE & CO | 6.4M | $1.09B | +17.6% | 6.364% | 0.06% |
| 3 | DODGE & COX | 5.6M | $941.2M | +2.3% | 5.554% | 0.49% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $838.3M | +5.2% | 4.947% | 0.04% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | $766.0M | +0.7% | 4.521% | 0.02% |
| 6 | STATE STREET CORP | 4.4M | $739.1M | +0.7% | 4.362% | 0.01% |
| 7 | AQR CAPITAL MANAGEMENT LLC | 3.8M | $643.5M | -22.7% | 3.797% | 0.22% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 2.3M | $393.7M | -3.4% | 2.323% | 0.54% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $359.6M | +0.1% | 2.127% | 0.02% |
| 10 | TWO SIGMA INVESTMENTS, LP | 2.1M | $349.9M | -32.2% | 2.065% | 0.25% |
| 11 | Vestal Point Capital, LP | 1.9M | $316.8M | +50.4% | 1.870% | 7.40% |
| 12 | BNP Paribas Asset Management Holding S.A. | 1.5M | $251.9M | +0.0% | 1.486% | 0.25% |
| 13 | MORGAN STANLEY | 1.3M | $222.2M | +8.2% | 1.311% | 0.01% |
| 14 | RTW INVESTMENTS, LP | 1.3M | $213.7M | +19.4% | 1.261% | 1.82% |
| 15 | NORTHERN TRUST CORP | 1.3M | $212.3M | +1.4% | 1.253% | 0.02% |
| 16 | Invesco Ltd. | 1.1M | $181.6M | +202.6% | 1.071% | 0.01% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 974K | $164.2M | +7.9% | 0.969% | 0.02% |
| 18 | NORGES BANK | 974K | $164.1M | β | 0.969% | 0.02% |
| 19 | FIRST TRUST ADVISORS LP | 923K | $155.6M | -3.8% | 0.918% | 0.09% |
| 20 | DIMENSIONAL FUND ADVISORS LP | 733K | $123.5M | +3.0% | 0.729% | 0.02% |
| 21 | JACOBS LEVY EQUITY MANAGEMENT, INC | 726K | $122.4M | +39.6% | 0.722% | 0.44% |
| 22 | Bank of New York Mellon Corp | 699K | $117.8M | -0.5% | 0.695% | 0.02% |
| 23 | Swedbank AB | 651K | $109.7M | +12.4% | 0.647% | 0.09% |
| 24 | VANGUARD FIDUCIARY TRUST CO | 648K | $109.2M | +2.1% | 0.644% | 0.02% |
| 25 | GOLDMAN SACHS GROUP INC | 646K | $108.8M | +77.9% | 0.642% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in NBIX β a direct measure of their conviction.
Filings activity in NBIX during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 778 | +13% | 100.95% | +0.34 pp | $16.54B | +29% |
| Q1 2026 | 691 | 3.1% | 100.61% | 0.30 pp | $12.85B | 3.7% |
| Q4 2025 | 713 | +13% | 100.91% | +2.03 pp | $13.34B | +4.2% |
| Q3 2025 | 629 | +9.4% | 98.88% | 1.39 pp | $12.80B | +10% |
| Q2 2025 | 575 | +1.8% | 100.27% | +4.15 pp | $11.60B | +19% |
| Q1 2025 | 565 | 2.4% | 96.12% | +3.08 pp | $9.78B | 17% |
| Q4 2024 | 579 | +6.0% | 93.04% | +2.18 pp | $11.80B | +19% |
| Q3 2024 | 546 | β | 90.86% | β | $9.91B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Neuroscience Biotech peers.
Quick answers to the most common questions about buying NBIX stock.
Based on Q2 2026 13F filings, institutional ownership of Neurocrine Biosciences, Inc. stands at 101.0%, held across 778 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of NBIX, with approximately 13,711,607 shares worth $2.31B as of Q2 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of NBIX, including RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for NBIX is 71 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
143 institutions opened new positions in NBIX during Q2 2026, while 62 fully exited. 534 added to existing positions and 81 trimmed.
NBIX institutional ownership rose by 0.34 percentage points quarter-over-quarter, with a net change of +87 holders.
The top 10 institutions account for 51.0% of all reported 13F value in NBIX, and the top 25 account for 66.5%.
Across the largest Neuroscience Biotech peers, institutional ownership levels are: DFTX (89.1%), HELP (49.7%), KRSA (10.0%), FLNA (28.5%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.